Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Mar;96(3):464-7.
doi: 10.3324/haematol.2010.033514. Epub 2010 Dec 6.

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma

Affiliations
Case Reports

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma

Kengo Takeuchi et al. Haematologica. 2011 Mar.

Abstract

ALK-positive large B-cell lymphoma is a rare subtype of lymphoma, and most cases follow an aggressive clinical course with a poor prognosis. We examined an ALK-positive large B-cell lymphoma case showing an anti-ALK immunohistochemistry pattern distinct from those of 2 known ALK fusions, CLTC-ALK and NPM-ALK, for the presence of a novel ALK fusion; this led to the identification of SQSTM1-ALK. SQSTM1 is an ubiquitin binding protein that is associated with oxidative stress, cell signaling, and autophagy. We showed transforming activities of SQSTM1-ALK with a focus formation assay and an in vivo tumorigenicity assay using 3T3 fibroblasts infected with a recombinant retrovirus encoding SQSTM1-ALK. ALK-inhibitor therapies are promising for treating ALK-positive large B-cell lymphoma, especially for refractory cases. SQSTM1-ALK may be a rare fusion, but our data provide novel biological insights and serve as a key for the accurate diagnosis of this rare lymphoma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Histopathology of SQSTM1-ALK-positive large B-cell lymphoma. (A) The pattern of tumor infiltration was diffuse. The lymphoma cells were large with abundant cytoplasm and had round, vesicular nuclei, each containing a centrally located large nucleolus. These features may be consistent with immunoblasts or plasmablasts, but the size of tumor cells was extremely large compared with these typical cell types (Magnification 40×). (B) Some lymphoma cells expressed cytokeratin (AE1/AE3) (Magnification 20×). (C) Syndecan1/CD138 was strongly expressed (Magnification 20×). (D) In anti-ALK immunohistochemistry, a diffuse cytoplasmic staining pattern with ill-demarcated spots was clearly shown (Magnification 20×).
Figure 2.
Figure 2.
Discovery of SQSTM-ALK fusion gene. (A) A chromosome translocation, t(2;5)(p23.1;q35.3), generates a cDNA fusion in which exon 5 of SQSTM is joined to the ALK cDNA for the intracellular region of its encoded protein (containing the tyrosine kinase domain). Numbers indicate amino acid positions of each protein. PB1: Phox and Bem1p; Z: atypical zinc finger; U: ubiquitin-associated. (B) A section of the specimen for the present case was subjected to FISH with an SQSTM1-ALK fusion assay. Nuclei are stained blue with DAPI. (C) Murine 3T3 fibroblasts were infected with retroviruses expressing SQSTM1-ALK. The cells were photographed after culture for 14 days. (D) A nude mouse was injected subcutaneously with 3T3 cells infected as in (C), and tumor formation was examined after 20 days.

References

    1. Delsol G, Lamant L, Mariame B, Pulford K, Dastugue N, Brousset P, et al. A new sub-type of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood. 1997;89(5):1483–90. - PubMed
    1. Beltran B, Castillo J, Salas R, Quinones P, Morales D, Hurtado F, et al. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. J Hematol Oncol. 2009;2:11. - PMC - PubMed
    1. Laurent C, Do C, Gascoyne RD, Lamant L, Ysebaert L, Laurent G, et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J Clin Oncol. 2009;27(25):4211–6. - PubMed
    1. Gascoyne RD, Lamant L, Martin-Subero JI, Lestou VS, Harris NL, Muller-Hermelink HK, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood. 2003;102(7):2568–73. - PubMed
    1. De Paepe P, Baens M, van Krieken H, Verhasselt B, Stul M, Simons A, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood. 2003;102(7):2638–41. - PubMed

Publication types

MeSH terms

Supplementary concepts

Associated data